glp-1 drugs pill form Eli Lilly Gets Speedy FDA Nod for Oral Drug, a Competitor to New Novo Nordisk Everything You Need to Know
Description
We do not yet have evidence that they're safe for people without obesity, diabetes, and/or cardiometabolic disease
Reduces the risk of complications GLP-1 agonists could reduce your risk of developing health conditions later in life
Acute administration of GLP-1 receptor agonists induces hypolocomotion but not anxiety in mice
Tirzepatide was shown to significantly reduce the apnea-hypopnea index in patients with obstructive sleep apnea
